Bryan Irving

2018

In 2018, Bryan Irving earned a total compensation of $1.4M as Executive Vice President and Chief Scientific Officer at Five Prime Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$135,580
Option Awards$671,379
Salary$383,489
Stock Awards$178,703
Other$6,072
Total$1,375,223

Irving received $671.4K in option awards, accounting for 49% of the total pay in 2018.

Irving also received $135.6K in non-equity incentive plan, $383.5K in salary, $178.7K in stock awards and $6.1K in other compensation.

Rankings

In 2018, Bryan Irving's compensation ranked 7,588th out of 14,244 executives tracked by ExecPay. In other words, Irving earned more than 46.7% of executives.

ClassificationRankingPercentile
All
7,588
out of 14,244
47th
Division
Manufacturing
2,947
out of 5,759
49th
Major group
Chemicals And Allied Products
1,105
out of 2,122
48th
Industry group
Drugs
935
out of 1,811
48th
Industry
Pharmaceutical Preparations
731
out of 1,385
47th

Pay ratio

Bryan Irving's Pay$1,375,223
Median Employee's Pay$201,670
Pay Ratio

7

to 1

In 2018, the annual total compensation of Bryan Irving was $1,375,223.

The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.

The ratio of Bryan Irving's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 29, 2019.

Irving's colleagues

We found six more compensation records of executives who worked with Bryan Irving at Five Prime Therapeutics in 2018.

2018

Aron Knickerbocker

Five Prime Therapeutics

Chief Executive Officer

2018

David Smith

Five Prime Therapeutics

Chief Financial Officer

2018

Helen Collins

Five Prime Therapeutics

Chief Medical Officer

2018

Francis Sarena

Five Prime Therapeutics

Secretary

2018

Linda Rubinstein

Five Prime Therapeutics

Chief Financial Officer

2018

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

News

You may also like